NEW YORK (GenomeWeb News) – AdvanDx has filed for 510(k) clearance from the US Food and Drug Administration for a molecular test that can detect an infectious yeast in blood cells. 
 
The company’s Yeast Traffic Light PNA FISH test detects up to five Candida yeast species from positive blood cultures in hours, rather days, AdvanDx said.
 
When it gets into the bloodstream, this yeast can cause Candidemia, which is frequently a hospital-acquired infection that affects over 24,000 US patients each year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.